GOOD

The Party Drug With The Power To Ease Anxiety, Depression, And PTSD

Should the FDA approve this Schedule 1 illegal substance as a prescription medication?

When New Yorker Stacy Berman was young, she would take MDMA (otherwise known as “molly” or “ecstacy”) once in awhile for recreational reasons. It just made her feel good, she says. So when she discovered as an adult that she’d been suffering from Complex Post Traumatic Stress Disorder (CPTSD)—often found in victims of child abuse and Holocaust survivors—she thought she’d give MDMA another try.


At the time, Berman was working to complete a doctoral program in mind/body medicine. She couldn’t believe how much MDMA helped. “The idea behind CPTSD is that in a situation where a person is not able to fight or flee, they tend to freeze up… MDMA allowed me to start feeling again,” she says.

[quote position="right" is_quote="false"]It’s difficult to set up and run clinical trials on MDMA because it’s a Schedule 1 illegal substance, like heroin.[/quote]

Researchers have been studying this party drug for years now, digging up compelling physiological and behavioral evidence that MDMA promotes strong feelings of empathy, closeness, and positivity. The substance is scientifically classified as an “empathogen” and was described by The Daily Beast as a “turbo-charged SSRI” (or antidepressant).

Over the years, the results have been so intriguing to leading Stanford neuroscientist/psychiatrist Robert Malenka and his colleague Boris Heifets, an anesthesiologist, that the two teamed up to argue that MDMA is worthy of rigorous scientific exploration. Their commentary appeared late last month in the journal Cell.

“For many decades both in my own work and as a well-trained neuroscientist, I've viewed psychoactive substances as valuable probes of the nervous system,” says Malenka. He’s especially fascinated by how MDMA evokes what he calls “a powerful pro-social effect.” In other words, it appears to promote “positive, good feelings towards another member of your species, rather than negative, aggressive feelings,” he says.

But it’s difficult to set up and run clinical trials on MDMA because it’s a Schedule 1 illegal substance, like heroin. The National Institute on Drug Abuse states that high doses of MDMA “can lead to a spike in body temperature that can occasionally result in liver, kidney, or heart failure or even death.” Overdoses and deaths at raves or festivals like 2013’s Electric Zoo shouldn’t be ignored. Still, Malenka and Heifets argue, trials on the safety and utility of MDMA have uncovered undeniable therapeutic potential. Notably, a 2011 controlled study of a group of PTSD sufferers published in the Journal of Psychopharmacology found that 83 percent of the participants who received MDMA no longer qualified as having PTSD by its end. Another study from 2016 showed that MDMA reduces social anxiety in autistic adults.

Before MDMA can be effectively utilized as a form of therapy, Malenka says its molecular underpinnings need to be better understood. Early research has suggested that MDMA may influence the release of the neurochemical oxytocin, the hormone essential to feelings of love and bonding in humans. But, says Malenka, “What hasn't been done is really trying to figure out which of those molecular targets are the most important for its pro-social effects—where in the brain those molecular targets are located.”

[quote position="left" is_quote="true"]One controlled study of PTSD sufferers found that 83 percent of the participants who received MDMA no longer qualified as having PTSD by its end.[/quote]

This is where the Multidisciplinary Association for Psychedelic Study (MAPS) comes in. Malenka credits the organization with having done a tremendous amount of work in raising awareness and lifting legislative and legal burdens to study MDMA. According to their website, “MAPS is undertaking a roughly $20 million plan to make MDMA into a Food and Drug Administration (FDA)-approved prescription medicine by 2021.”

Compass, which is pushing for similar goals but primarily for psilocybin (mushrooms), also focuses on “accelerating access to evidence-led innovation in mental health and well-being,” according to its co-founder and director George Goldsmith.

Goldsmith is optimistic about the future of hallucinogenic-based drug therapies. “We think there could be great promise in combining these medicines to create a greater sense of openness with a new therapy in a careful, supportive environment,” he says, adding that they have no intention of eventually pushing these kinds of drugs “at CVS or Walgreens.”

Berman, who went on to finish her doctoral program and found her own integrated wellness startup, agrees. After taking MDMA an estimated six or seven more times over a five-year period—in combination with therapy and meditation—Berman feels that it allowed her to “open up and feel vulnerable again and trust people.” Her encounter with MDMA’s therapeutic purposes inspired her to more deeply research what was behind the “profound feelings of love and connection” she’d experienced. After looking into a number of studies, Berman feels confident stating that the MDMA “literally rewired my brain in a way that allowed me to start feeling and then to process the good and the bad.”

Of course, Berman recommends caution and care when pursuing this illicit substance, both because it is illegal and because she feels anyone intending to take it must “always know and trust the person who has given it to you. Be in a safe environment.”

Health
via Real Time with Bill Maher / YouTube and The Late Late Show with James Corden / YouTube

A controversial editorial on America's obesity epidemic and healthcare by comedian Bill Maher on his HBO show "Real Time" inspired a thoughtful, and funny, response by James Cordon. It also made for a great debate about healthcare that Americans are avoiding.

At the end of the September 6th episode of "Real Time, " Maher turned to the camera for his usual editorial and discussed how obesity is a huge part of the healthcare debate that no one is having.

"At Next Thursday's debate, one of the candidates has to say, 'The problem with our healthcare system is Americans eat shit and too much of it.' All the candidates will mention their health plans but no one will bring up the key factor: the citizens don't lift a finger to help," Maher said sternly.

Keep Reading Show less
Politics

There is no shortage of proposals from the, um, what's the word for it… huge, group of Democratic presidential candidates this year. But one may stand out from the pack as being not just bold but also necessary; during a CNN town hall about climate change Andrew Yang proposed a "green amendment" to the constitution.

Keep Reading Show less
test
Me Too Kit

The creator of the Me Too kit — an at home rape kit that has yet to hit the market — has come under fire as sexual assault advocates argue the kit is dangerous and misleading for women.

The kit is marketed as "the first ever at home kit for commercial use," according to the company's website. "Your experience. Your kit. Your story. Your life. Your choice. Every survivor has a story, every survivor has a voice." Customers will soon be able order one of the DIY kits in order to collect evidence "within the confines of the survivor's chosen place of safety" after an assault.

"With MeToo Kit, we are able to collect DNA samples and other tissues, which upon testing can provide the necessary time-sensitive evidence required in a court of law to identify a sexual predator's involvement with sexual assault," according to the website.

Keep Reading Show less
Health

Villagers rejoice as they receive the first vaccines ever delivered via drone in the Congo

The area's topography makes transporting medicines a treacherous task.

Photo by Henry Sempangi Senyule

When we discuss barriers to healthcare in the developed world, affordability is commonly the biggest concern. But for some in the developing world, physical distance and topography can be the difference between life and death.

Widjifake, a hard-to-reach village in northwestern Democratic Republic of Congo (DRC) with a population of 6,500, struggles with having consistent access to healthcare supplies due to the Congo River and its winding tributaries.

It can take up to three hours for vehicles carrying supplies to reach the village.

Keep Reading Show less
Health
via Keith Boykin / Twitter

Fox News and President Trump seem like they may be headed for a breakup. "Fox is a lot different than it used to be," Trump told reporters in August after one of the network's polls found him trailing for Democrats in the 2020 election.

"There's something going on at Fox, I'll tell you right now. And I'm not happy with it," he continued.

Some Fox anchors have hit back at the president over his criticisms. "Well, first of all, Mr. President, we don't work for you," Neil Cavuto said on the air. "I don't work for you. My job is to cover you, not fawn over you or rip you, just report on you."

Keep Reading Show less
Politics